Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
Artigo em Inglês | WPRIM | ID: wpr-981107

RESUMO

OBJECTIVES@#This study aims to explore the therapeutic targets of curcumin in periodontitis through network pharmacology and molecular docking technology.@*METHODS@#Targets of curcumin and periodontitis were predicted by different databases, and the protein-protein interaction (PPI) network constructed by String revealed the interaction between curcumin and periodontitis. The key target genes were screened for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Molecular docking was performed to analyze the binding potential of curcumin to periodontitis.@*RESULTS@#A total of 672 periodontitis-related disease targets and 107 curcumin-acting targets were obtained from the databases, and 20 key targets were screened. The GO and KEGG analyses of the 20 targets showed that curcumin might play a therapeutic role through the hypoxia-inducible factor (HIF)-1 and parathyroid hormone (PTH) signaling pathways. Molecular docking analysis showed that curcumin had good binding potential with multiple targets.@*CONCLUSIONS@#The potential key targets and molecular mechanisms of curcumin in treating periodontitis provide a theoretical basis for new drug development and clinical applications.


Assuntos
Humanos , Farmacologia em Rede , Curcumina/uso terapêutico , Simulação de Acoplamento Molecular , Periodontite/tratamento farmacológico , Medicamentos de Ervas Chinesas , Medicina Tradicional Chinesa
2.
Chin. j. integr. med ; Chin. j. integr. med;(12): 387-393, 2023.
Artigo em Inglês | WPRIM | ID: wpr-982304

RESUMO

OBJECTIVE@#To assess the efficacy of a curcumin supplementation on cognitive abilities in women suffering from premenstrual syndrome (PMS) and dysmenorrhea.@*METHODS@#A randomized, triple-blind, placebo-controlled trial was conducted from December 2019 to March 2020. A total of 124 women who had both PMS and dysmenorrhea were enrolled, and were equally and randomly assigned to the curcumin group or placebo group, 62 cases in each. Each subject received either a capsule containing 500 mg of curcuminoid, or a placebo daily, for 10 days (7 days before and until 3 days after the onset of menstrual bleeding) over 3 menstrual cycles. The cognitive abilities questionnaire was used to measures cognitive functions in 7 specific areas. Adverse reactions were monitored during and after the trial in both groups.@*RESULTS@#Administration of curcumin was associated with a significant increase in memory score (P=0.002), inhibitory control and selective attention (P=0.020), and total cognitive ability task (P=0.024). In addition, significant increments were found in scores of memory (3.5±3.1 vs. 0.4±3.8 in the curcumin and placebo groups, respectively; P=0.035), inhibitory control and selective attention (3.0±3.7 vs. 0.4±3.7; P=0.027) and total cognitive abilities (8.3±12.3 vs. 2.2±12.4; P=0.025) in the curcumin group versus placebo groups. Curcumin was safe and well-tolerable in current clinical trial.@*CONCLUSION@#Curcumin has a beneficial efficacy on cognitive function scores in women with PMS and dysmenorrhea, with improvements in memory, inhibitory control and selective attention. (Registration No. IRCT20191112045424N1, available at: https://www.irct.ir ).


Assuntos
Humanos , Feminino , Curcumina/uso terapêutico , Dismenorreia/tratamento farmacológico , Síndrome Pré-Menstrual/psicologia , Cognição , Método Duplo-Cego
3.
Journal of Integrative Medicine ; (12): 226-235, 2023.
Artigo em Inglês | WPRIM | ID: wpr-982675

RESUMO

Diabetes mellitus is a chronic disease, typified by hyperglycemia resulting from failures in complex multifactorial metabolic functions, that requires life-long medication. Prolonged uncontrolled hyperglycemia leads to micro- and macro-vascular complications. Although antidiabetic drugs are prescribed as the first-line treatment, many of them lose efficacy over time or have severe side effects. There is a lack of in-depth study on the patents filed concerning the use of natural compounds to manage diabetes. Thus, this patent analysis provides a comprehensive report on the antidiabetic therapeutic activity of 6 phytocompounds when taken alone or in combinations. Four patent databases were searched, and 17,649 patents filed between 2001 and 2021 were retrieved. Of these, 139 patents for antidiabetic therapeutic aids that included berberine, curcumin, gingerol, gymnemic acid, gymnemagenin and mangiferin were analyzed. The results showed that these compounds alone or in combinations, targeting acetyl-coenzyme A carboxylase 2, serine/threonine protein kinase, α-amylase, α-glucosidase, lipooxygenase, phosphorylase, peroxisome proliferator-activated receptor-γ (PPARγ), protein tyrosine phosphatase 1B, PPARγ co-activator-1α, phosphoinositide 3-kinase and protein phosphatase 1 regulatory subunit 3C, could regulate glucose metabolism which are validated by pharmacological rationale. Synergism, or combination therapy, including different phytocompounds and plant extracts, has been studied extensively and found effective, whereas the efficacy of commercial drugs in combination with phytocompounds has not been studied in detail. Curcumin, gymnemic acid and mangiferin were found to be effective against diabetes-related complications. Please cite this article as: DasNandy A, Virge R, Hegde HV, Chattopadhyay D. A review of patent literature on the regulation of glucose metabolism by six phytocompounds in the management of diabetes mellitus and its complications. J Integr Med. 2023; 21(3): 226-235.


Assuntos
Humanos , PPAR gama/metabolismo , Curcumina/uso terapêutico , Fosfatidilinositol 3-Quinases , Diabetes Mellitus/tratamento farmacológico , Hipoglicemiantes/farmacologia , Hiperglicemia/tratamento farmacológico , Glucose
4.
Chin. j. integr. med ; Chin. j. integr. med;(12): 699-706, 2023.
Artigo em Inglês | WPRIM | ID: wpr-1010277

RESUMO

OBJECTIVE@#To explore the effect of curcumin on the proliferation of renal cell carcinoma and analyze its regulation mechanism.@*METHODS@#In RCC cell lines of A498 and 786-O, the effects of curcumin (2.5, 5, 10 µ mo/L) on the proliferation were analyzed by Annexin V+PI staining. Besides, A498 was inoculated into nude mice to establish tumorigenic models, and the model mice were treated with different concentrations of curcumin (100, 200, and 400 mg/kg), once daily for 30 days. Then the tumor diameter was measured, the tumor cells were observed by hematoxylin-eosin staining, and the protein expressions of miR-148 and ADAMTS18 were detected by immunohistochemistry. In vitro, after transfection of miR-148 mimics, miR-148 inhibitor or si-ADAMTS18 in cell lines, the expression of ADAMTS18 was examined by Western blotting and the cell survival rate was analyzed using MTT. Subsequently, Western blot analysis was again used to examine the autophagy phenomenon by measuring the relative expression level of LC3-II/LC3-I; autophagy-associated genes, including those of Beclin-1 and ATG5, were also examined when miR-148 was silenced in both cell lines with curcumin treatment.@*RESULTS@#Curcumin could inhibit the proliferation of RCC in cell lines and nude mice. The expression of miR-148 and ADAMTS18 was upregulated after curcumin treatment both in vitro and in vivo (P<0.05). The cell survival rate was dramatically declined upon miR-148 or ADAMTS18 upregulated. However, si-ADAMTS18 treatment or miR-148 inhibitor reversed these results, that is, both of them promoted the cell survival rate.@*CONCLUSION@#Curcumin can inhibit the proliferation of renal cell carcinoma by regulating the miR-148/ ADAMTS18 axis through the suppression of autophagy in vitro and in vivo. There may exist a positive feedback loop between miR-148 and ADAMTS18 gene in RCC.


Assuntos
Animais , Camundongos , Carcinoma de Células Renais/metabolismo , Curcumina/uso terapêutico , MicroRNAs/metabolismo , Camundongos Nus , Linhagem Celular Tumoral , Neoplasias Renais/metabolismo , Autofagia , Proliferação de Células , Regulação Neoplásica da Expressão Gênica , Proteínas ADAMTS/metabolismo
5.
Journal of Integrative Medicine ; (12): 193-203, 2022.
Artigo em Inglês | WPRIM | ID: wpr-929228

RESUMO

Metabolic syndrome (MS) involves people with the following risk factors: obesity, hypertension, high glucose level and hyperlipidemia. It can increase the risk of heart disease, stroke and type 2 diabetes mellitus. The prevalence of MS in the world's adult population is about 20%-25%. Today, there is much care to use medicinal plants. Turmeric (Curcuma longa) as well as curcumin which is derived from the rhizome of the plant, has been shown beneficial effects on different components of MS. Thus, the purpose of this manuscript was to introduce different in vitro, in vivo and human studies regarding the effect of turmeric and its constituent on MS. Moreover, different mechanisms of action by which this plant overcomes MS have been introduced. Based on studies, turmeric and its bioactive component, curcumin, due to their anti-inflammatory and antioxidant properties, have antidiabetic effects through increasing insulin release, antihyperlipidemic effects by increasing fatty acid uptake, anti-obesity effects by decreasing lipogenesis, and antihypertensive effects by increasing nitric oxide. According to several in vivo, in vitro and human studies, it can be concluded that turmeric or curcumin has important values as a complementary therapy in MS. However, more clinical trials should be done to confirm these effects.


Assuntos
Humanos , Curcuma , Curcumina/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Síndrome Metabólica/tratamento farmacológico , Extratos Vegetais/uso terapêutico , Rizoma
6.
J. biomed. eng ; Sheng wu yi xue gong cheng xue za zhi;(6): 1158-1164, 2022.
Artigo em Chinês | WPRIM | ID: wpr-970654

RESUMO

This study aimed to investigate the effect of curcumin (Cur) against human cytomegalovirus (HCMV) in vitro. Human embryonic lung fibroblasts were cultured in vitro. The tetrazolium salt (MTS) method was used to detect the effects of Cur on cell viability. The cells were divided into control group, HCMV group, HCMV + (PFA) group and HCMV + Cur group in this study. The cytopathic effect (CPE) of each group was observed by plaque test, then the copy number of HCMV DNA in each group was detected by quantitative polymerase chain reaction (qPCR), and the expression of HCMV proteins in different sequence was detected by Western blot. The results showed that when the concentration of Cur was not higher than 15 μmol/L, there was no significant change in cell growth and viability in the Cur group compared with the control group (P>0.05). After the cells were infected by HCMV for 5 d, the cells began to show CPE, and the number of plaques increased with time. Pretreatment with Cur significantly reduced CPE in a dose-dependent manner. After the cells were infected by HCMV, the DNA copy number and protein expression gradually increased in a time-dependent manner. Pretreatment with Cur significantly inhibited HCMV DNA copies and downregulate HCMV protein expression levels in a concentration-dependent manner, and the difference was statistically significant (P<0.05). In conclusion, Cur may exert anti-HCMV activity by inhibiting the replication of HCMV DNA and down-regulating the expression levels of different sequence proteins of HCMV. This study provides a new experimental basis for the development of anti-HCMV infectious drugs.


Assuntos
Humanos , Curcumina/uso terapêutico , Citomegalovirus/genética , Infecções por Citomegalovirus/tratamento farmacológico , Placa Aterosclerótica
8.
Cienc. tecnol. salud ; 7(3): 412-441, 26 de noviembre 2020. 27 cmilus
Artigo em Espanhol | LILACS, DIGIUSAC, LIGCSA | ID: biblio-1141472

RESUMO

Las infecciones respiratorias constituyen una importante causa de morbilidad y mortalidad a nivel mundial, incrementándose su relevancia ante la reciente infección por SARS-CoV-2, causante de la pandemia de COVID-19. Las opciones terapéuticas para esta infección respiratoria son escasas y sin eficacia comprobada. El objetivo de esta revisión fue buscar la información sobre plantas con actividad antiviral o viricida publicada en los últimos 10 años, en las bases de datos de Google Scholar, Scopus y PubMed. La búsqueda priorizó aquellas especies disponibles en Guatemala, la cual se complementó con la búsqueda de moléculas con actividad antiviral para finalmente postular aquellas que puedan prevenir la infección o aminorar la patogénesis del SARS-CoV-2. Se detectaron más de 170 especies con actividad antiviral y se organizó la información por país o región y tipo de actividad antiviral contra virus específicos. De las especies de mayor disponibilidad en Guatemala se seleccionaron 20. La revisión culmina con 15 artículos que proponen plantas o moléculas con potencial actividad específica en el manejo de la pandemia por SARS-CoV-2. Se concluye que existen especies vegetales (Curcuma longa, Echinacea purpurea, Psidium guajava, Allium sativum, Salvia officinalis y Eucalyptus globulus) y fitocompuestos vegetales (hesperidina, rutina, diosmina, apiina, aloe-emodina, piperina, capsaicina, curcumina, oleuropeina, rhamnetina y gallato de epicatequina) que podrían contribuir al manejo de la enfermedad. Se insta a académicos y autoridades a poner más atención a estas opciones terapéuticas que nos ofrece la naturaleza y que podrían contribuir a aliviar el colapso de los sistemas de salud prevalentes.


Respiratory infections are an important cause of morbidity and mortality worldwide, increasing their relevance by the recent SARS-CoV-2 infection causing the COVID-19 pandemic. Therapeutic options for this respiratory infection are scarce and without proven effectiveness. The objective of this review was the search for information on plants with antiviral or viricidal activity published in the last 10 years in the Google Scholar, Scopus, and PubMed databases. The search prioritized those species available in Guatemala, was completed with the search of molecules with potential to prevent infection or reduce the activity of SARS-CoV-2 infection. More than 170 species with antiviral activity were detected and the information organized in surveys by country or region, activity against specific viruses and antiviral information on the 20 most commonly available species in the country. It is complemented with a summary of 15 articles that proposed plants or molecules with potential specific activity in the management of the SARS-CoV-2 pandemic. It is concluded there are plant species (Curcuma longa, Echinacea purpurea, Psidium guajava, Allium sativum, Salvia officinalis and Eucalyptus globulus) and phytocompounds isolated from these species (hesperidin, rutin, diosmin, apiine, aloe-emodin, piperine, capsaicin, curcumin, oleuropein and epicatechin gallate) that could contribute to the management of the disease. Academics and authorities are urged to pay more attention to these therapeutic options that nature offer to us and could contribute to alleviate the collapse of the prevailing health systems in the country.


Assuntos
Humanos , Plantas Medicinais/efeitos dos fármacos , Infecções Respiratórias , Terapêutica , Catequina/uso terapêutico , Echinacea , Curcumina/uso terapêutico , Salvia officinalis , Psidium , Diosmina , Aloe , Eucalyptus , Betacoronavirus , Alho , COVID-19 , Guatemala , Hesperidina
9.
IBJ-Iranian Biomedical Journal. 2018; 22 (3): 171-179
em Inglês | IMEMR | ID: emr-192466

RESUMO

Background: Curcumin, extracted from turmeric, represents enormous potential to serve as an anticancer agent. Telomerase is viewed as a prominent molecular target of curcumin, and transforming growth factor- beta 1 [TGF beta 1] has proven to be a major inhibitory signaling pathway for telomerase activity. In the current study, we aimed to explore suppressive effects of nanocurcumin on telomerase expression through TGF beta 1 pathway in a hepatocellular carcinoma cell line [Huh7]


Methods: MTT assay was used to determine the effect of nonocurcumin on viability of Huh7 cells. RT-PCR was used to analyze the gene expression patterns


Results: MTT assay revealed that nanocurcumin acts in a dose- and time-dependent manner to diminish the cell viability. RT-PCR analysis indicated that nanocurcumin results in augmentation of TGF beta 1 72 hours post treatment and leads to the reduction of telomerase expression 48 and 72 hours post exposure. Also, up-regulation of Smad3 and E2F1 and down-regulation of Smad7 confirmed the effect of nanocurcumin on intermediate components of TGF beta 1 pathway. Furthermore, transfection of the proximal promoter of telomerase triggered a significant reduction in luciferase activity


Conclusion: The data from the present study lead us to develop a deeper understanding of the mechanisms underlying nanocurcumin-mediated regulation of telomerase expression, thereby presenting a new perspective to the landscape of using nanocurcumin as a cancer-oriented therapeutic agent


Assuntos
Animais de Laboratório , Neoplasias Hepáticas/terapia , Neoplasias Hepáticas/genética , Curcumina/uso terapêutico , Telomerase , Expressão Gênica , Fator de Crescimento Transformador beta1
10.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;75(8): 546-552, Aug. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-888308

RESUMO

ABSTRACT Recent studies have demonstrated that curcumin (Cur) has antioxidant, anti-inflammatory and anti-fibrotic effects. Ethidium bromide (EB) injections into the central nervous system (CNS) are known to induce local oligodendroglial and astrocytic loss, resulting in primary demyelination and neuroinflammation. Peripheral astrogliosis is seen around the injury site with increased immunoreactivity to glial fibrillary acidic protein (GFAP). This investigation aimed to evaluate the effect of Cur administration on astrocytic response following gliotoxic injury. Wistar rats were injected with EB into the cisterna pontis and treated, or not, with Cur (100 mg/kg/day, intraperitoneal route) during the experimental period. Brainstem sections were collected at 15, 21 and 31 days after EB injection and processed for GFAP immunohistochemical staining. Astrocytic reactivity was measured in a computerized system for image analysis. In Cur-treated rats, the GFAP-stained area around the lesion was significantly smaller in all periods after EB injection compared to untreated animals, showing that Cur reduces glial scar development following injury.


RESUMO Estudos recentes têm demonstrado que a curcumina (Cur) possui efeitos antioxidantes, anti-inflamatórios e antifibróticos. Sabe-se que a injeção de brometo de etídio (EB) no sistema nervoso central induz a perda oligodendroglial e astrocitária, resultando em desmielinização primária e neuroinflamação. Astrogliose periférica é observada ao redor da lesão com aumento da imunorreatividade à proteína glial fibrilar ácida (GFAP). A presente investigação objetivou avaliar o efeito da Cur sobre a resposta astrocitária após injúria gliotóxica. Ratos Wistar foram injetados com EB na cisterna basal e tratados ou não com Cur (100 mg/kg/dia, via intraperitoneal) durante o período experimental. Amostras do tronco encefálico foram coletadas aos 15, 21 e 31 dias pós-injeção de EB e processadas para estudo imuno-histoquímico para a GFAP. A reatividade astrocitária foi medida em um sistema computadorizado para análise de imagem. Nos ratos tratados com Cur, a área marcada para GFAP foi significantemente menor em todos os períodos pós-injeção de EB, indicando que a Cur reduz o desenvolvimento da cicatriz glial após injúria.


Assuntos
Animais , Masculino , Ratos , Tronco Encefálico/patologia , Astrócitos/efeitos dos fármacos , Doenças Desmielinizantes/patologia , Curcumina/uso terapêutico , Coloração e Rotulagem , Tronco Encefálico/efeitos dos fármacos , Anti-Inflamatórios não Esteroides/uso terapêutico , Anti-Inflamatórios não Esteroides/farmacologia , Astrócitos/patologia , Doenças Desmielinizantes/induzido quimicamente , Ratos Wistar , Curcumina/farmacologia , Modelos Animais de Doenças , Etídio , Proteína Glial Fibrilar Ácida/metabolismo
12.
Journal of Medicinal Plants. 2017; 16 (Supp. 10): 174-184
em Persa | IMEMR | ID: emr-185706

RESUMO

Background: Help to return people who have social disorders, including alcohol consumption, are the important topics of research in the field of biology, which in this area regarding the efficiency of the pharmacological interventions and physical activity


Objective: The aim of this study was to compare the effects of two weeks of swimming training or curcumin supplementation on spatial memory improved after the destruction caused by the binge ethanol drinking in male rats


Methods: In an experimental trial, 24 Wistar rats [male, 200-250 g] were selected and every eight hours one time received ethanol for 4 days. After six days of abstain, for 2-weeks interventions of the swimming and curcumin supplementation was applied. The rats were randomly divided into three groups: 1] control; 2] swim; and 3] curcumin. After 2-weeks by using the Morris Water Maze, learning and spatial memory were assessed


Results: After 2-weeks of swimming training and curcumin supplementation, time and distance to reach the platue found a significant reduction, which represents the process of learning [P < 0.05]. The amount of this reduction was larger in curcumin group than the other groups. No significant difference was observed between the effects of interventions in spatial memory [P > 0.05]


Conclusion: Despite the slight improvement in the training and curcumin groups compared to control group, two weeks of swimming or curcumin supplementation can not improve spatial memory after binge ethanol drinking. According to the results of this study concludes that learning performance during the period of recovery after ethanol consumption under the influence of two weeks aerobic exercise and curcumin supplementation, but spatial memory dose not affected by these two interventions


Assuntos
Animais de Laboratório , Masculino , Transtornos da Memória/terapia , Terapia por Exercício , Fitoterapia , Curcumina/uso terapêutico , Consumo Excessivo de Bebidas Alcoólicas , Ratos Wistar
13.
Rev. cuba. plantas med ; 21(4)oct.-dic. 2016. ilus, tab
Artigo em Espanhol | LILACS, CUMED | ID: biblio-960662

RESUMO

Introducción: la curcumina es el principal compuesto polifenólico bioactivo de la planta Curcuma longa. Esta molécula ha mostrado efectos antioxidantes, anti-inflamatorios y anticancerígenos en diferentes modelos experimentales. Como parte de su actividad benéfica en células tumorales, se le ha asociado con la regulación de mecanismos epigenéticos, modulando así diferentes vías de señalización, entre ellas la vía Wnt/ß-catenina, la cual juega un papel fundamental en el desarrollo de cáncer. Objetivos: describir los avances científicos en el estudio de la actividad anti-cancerígena de la curcumina en relación a la modulación de mecanismos epigenéticos y su implicación en la vía Wnt/ß-catenina. Métodos: se realizó una búsqueda sistemática en las bases de datos PubMed, Google Scholar, Scopus y ScienceDirect, utilizando los siguientes criterios de búsqueda: curcumina, epigenética, Wnt/ß-catenina y cáncer. Se incluyeron artículos con importancia científica entre los años 2001-2016, que exploraran la actividad inhibitoria de la curcumina sobre la maquinaria epigenética y/o que evidenciaran un efecto regulador sobre alteraciones en la vía Wnt/ß-catenina. Resultados: se encontró en la literatura una creciente evidencia que involucra a la curcumina con la inhibición de la actividad de enzimas ADN metiltransferasas, acetiltransferasas y desacetilasas de histonas, y por ende en la regulación de alteraciones epigenéticas. Esto lleva a la re-expresión de genes silenciados en diversos tipos de cáncer, lo cual le confiere una actividad antitumoral asociada a la regulación de vías de señalización. En este contexto, se ha demostrado que la curcumina actúa sobre componentes de la vía Wnt/ß-catenina e incluso regula su actividad mediante la desmetilación de antagonistas de Wnt. Conclusiones: este manuscrito discute los potenciales efectos quimiopreventivos de la curcumina asociados con restauración de los mecanismos epigenéticos y la vía de señalización Wnt/ß-catenina(AU)


Introduction: Curcumin is the main bioactive polyphenolic compound in the plant Curcuma longa. This molecule has displayed antioxidant, anti-inflammatory and anti-cancer activity in various experimental models. Its beneficial effect on tumor cells has been associated with the regulation of epigenetic mechanisms, modulating various signaling pathways, among them the Wnt/-catenin pathway, which plays a fundamental role in cancer development. Objectives: Describe the scientific progress achieved in the study of the anti-cancer activity of curcumin in relation to the modulation of epigenetic mechanisms and its implication for the Wnt/?-catenin pathway. Methods: A systematic search was conducted in the databases PubMed, Google Scholar, Scopus and ScienceDirect, using the search terms curcumin, epigenetics, Wnt/?-catenin and cancer. Papers were included which had scientific relevance, had been published between 2001 and 2016, explored the inhibitory activity of curcumin on the epigenetic machinery and/or presented evidence of a regulatory effect on alterations in the Wnt/?-catenin pathway. Results: Growing evidence was found in the literature associating curcumin with inhibition of the activity of the enzymes histone deacetylases, acetyltransferases and DNA methyltransferases, and therefore regulation of epigenetic alterations. This leads to re-expression of silenced genes in various cancer types, granting it antitumor activity associated with the regulation of signaling pathways. In this context, it has been proved that curcumin acts upon components of the Wnt/?-catenin pathway and even regulates their activity through demethylation of Wnt antagonists. Conclusions: The paper discusses the potential chemopreventive effects of curcumin associated with restoration of epigenetic mechanisms and the Wnt/-catenin signaling pathway(AU)


Assuntos
Humanos , Curcumina/uso terapêutico , Epigenômica , Antineoplásicos Fitogênicos/uso terapêutico
14.
Acta cir. bras ; Acta cir. bras;31(11): 706-713, Nov. 2016. tab, graf
Artigo em Inglês | LILACS | ID: biblio-827661

RESUMO

ABSTRACT PURPOSE: To investigate the effect of curcumin on visfatin and zinc-α2-glycoprotein (ZAG) expression levels in rats with non-alcoholic fatty liver disease (NAFLD). METHODS: Fifty-six male rats were randomly divided into a control group (n=16) and model group (n=40) and were fed on a normal diet or a high-fat diet, respectively. Equal volumes of sodium carboxymethyl cellulose (CMC) were intragastrically administered to the control group for 4 weeks. At the end of the 12th week, visfatin and ZAG protein expression levels were examined by immunohistochemistry. Visfatin mRNA levels were measured by semi-quantitative reverse transcription polymerase chain reaction. RESULTS: Compared with the control group, the model group showed significantly increased expression of visfatin in liver tissue (P < 0.01) and significantly decreased expression of ZAG (P < 0.01). These effects were ameliorated by curcumin treatment. CONCLUSIONS: Visfatin and zinc-α2-glycoprotein may be involved in the pathogenesis of NAFLD. Treatment of NAFLD in rats by curcumin may be mediated by the decrease of visfatin and the increase of non-alcoholic fatty liver disease.


Assuntos
Animais , Masculino , Ratos , Anti-Inflamatórios não Esteroides/uso terapêutico , Curcumina/uso terapêutico , Proteínas de Plasma Seminal/metabolismo , Nicotinamida Fosforribosiltransferase/metabolismo , Ácidos Graxos/metabolismo , Hepatopatia Gordurosa não Alcoólica/metabolismo , Triglicerídeos/sangue , Distribuição Aleatória , Anti-Inflamatórios não Esteroides/administração & dosagem , Colesterol/sangue , Ratos Sprague-Dawley , Curcumina/administração & dosagem , Alanina Transaminase/sangue , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico , Fígado/patologia , Antioxidantes/administração & dosagem , Antioxidantes/uso terapêutico
15.
Rev. ADM ; 73(5): 245-249, sept.-oct. 2016.
Artigo em Espanhol | LILACS | ID: biblio-835302

RESUMO

La curcumina es una sustancia derivada de una planta llamada Curcuma longa. A esta sustancia se le han atribuido diversos efectos terapéuticos. En relación con la clínica dental, se ha observado que, además de ayudaren el control del dolor, ha sido efectiva contra la periodontitis, estomatitis y mucositis pediátrica. El control del dolor e inflamación son aspectos muy importantes para la mayoría de los tratamientos en odontología; la búsqueda de nuevas alternativas analgésicas y antiinflamatorias que, en comparación con las actuales, sean más eficientes, efectivas y tengan menos efectos colaterales es uno de los grandes retos de las ciencias biomédicas. La presente revisión muestra algunas evidencias científicas de los efectos de la curcumina como un antiinflamatorio y analgésico, con el propósito de sentar las bases para futuros estudios clínicos y de ciencia básica que aporten un mayor entendimiento de los procesos celulares, bioquímicos, moleculares, fisiológicos y farmacológicos de la curcumina como una sustancia potencialmente útilen el consultorio dental.


Curcumin is a substance derived from the plant Curcuma longa andone that has been attributed a range of therapeutic eff ects. In dentalpractice, curcumin has not only been found to help with pain control, buthas also been eff ective against periodontitis, stomatitis, and pediatricmucositis. Controlling pain and infl ammation are both very importantaspects of most dental treatments. The search for more effi cient andeff ective analgesic and anti-infl ammatory alternatives with fewerside eff ects compared to those currently used is one of the greatestchallenges for biomedical science. This review presents some of thescientifi c evidence of the eff ects of curcumin, both as an analgesic andan anti-infl ammatory agent, in order to establish the foundations forfurther clinical and basic science studies that will provide a greaterunderstanding of the cellular, biochemical, molecular, physiological,and pharmacological processes of curcumin as a potentially usefulsubstance in dental practice.


Assuntos
Humanos , Analgésicos/classificação , Anti-Inflamatórios não Esteroides/classificação , Curcumina/farmacologia , Curcumina/uso terapêutico , Antineoplásicos/classificação , Antineoplásicos/uso terapêutico , Antissépticos Bucais/classificação , Antissépticos Bucais/uso terapêutico , Doenças Periodontais/tratamento farmacológico , Estomatite/tratamento farmacológico
16.
Rev. bras. epidemiol ; Rev. bras. epidemiol;18(supl.2): 146-157, Out.-Dez. 2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-776710

RESUMO

RESUMO: Objetivo: Descrever o perfil dos pacientes que referiram diagnóstico médico de câncer e descrever os tipos de câncer mais prevalentes, segundo variáveis selecionadas. Métodos: Estudo descritivo que utilizou dados da Pesquisa Nacional de Saúde (PSN) de 2013 para estimar prevalências e respectivos valores do intervalo de confiança (IC95%). Resultados: Menos de 2% dos adultos referiram diagnóstico médico de câncer, sendo mais relatado por mulheres, por pessoas com mais de 60 anos, entre brancos, em residentes da zona urbana e moradores da Região Sul. O câncer de próstata foi o mais referido entre os homens; entre as mulheres, o câncer de mama foi o mais prevalente. A menor idade média do primeiro diagnóstico foi identificada para câncer de colo de útero (35,4 anos; IC95% 30,3 - 40,6), e a maior, para câncer de próstata (65,7 anos; IC95% 64,2 - 67,0). Conclusão: Os achados deste estudo são importantes para o planejamento dos serviços de saúde e do seu acesso, pois revelam diferenças, principalmente regionais.


ABSTRACT: Objective: To describe the profile of patients who reported a medical diagnosis of cancer and describe the most prevalent types of cancer, according to selected variables. Methods: A descriptive study that used data from the National Survey of Health, 2013, to estimate prevalence and their values of confidence interval (95%CI). Results: Less than 2% of adults reported a medical diagnosis of cancer, with most reported by women, people over 60, among whites, residents in the village and residents of South Prostate cancer was the most reported among men and breast among women. The lowest average age of first diagnosis was identified for cervical cancer (35.4 years; 95%CI 30.3 - 40.6) and the highest for prostate (65.7 years; 95%CI 64.2 - 67.0). Conclusion: The findings of this study are important for the planning of health services and access, as they show differences mainly regional.


Assuntos
Animais , Camundongos , Anti-Inflamatórios/uso terapêutico , Curcumina/uso terapêutico , Portadores de Fármacos , Interleucina-1beta/genética , Lipídeos/química , Lipopolissacarídeos/toxicidade , Nanopartículas , Sepse/tratamento farmacológico , Citocinas/sangue , Mediadores da Inflamação/metabolismo , Camundongos Transgênicos , Regiões Promotoras Genéticas , Transdução de Sinais , Sepse/induzido quimicamente
17.
Artigo em Inglês | IMSEAR | ID: sea-158244

RESUMO

Background of the Study: The aim of this study is to evaluate the efficacy of natural curcumin in the management of chronic periodontitis as local drug delivery in comparison to synthetic chlorhexidine, which is the gold standard. Materials and Methods: Thirty chronic periodontitis patients with an age range of 20–50 years with probing pocket depth (PPD) of 4–6 mm were included. Curcumin and chlorhexidine gel was applied in the contralateral disease sites at baseline and day 15. The clinical parameters like PPD, clinical attachment level (CAL), gingival index (Loe and Silness) and plaque index (Turesky Gillmore modification of Quigley Hein) were recorded and colony forming units (CFU) were assessed microbiologically at baseline, 15 and 30 days. Results: There was a significant reduction of the clinical parameters (PPD, CAL) and microbiological parameters CFU at 15 and 30 days for both the groups. Curcumin group showed a greater reduction in the clinical parameters when compared with chlorhexidine group. Both groups had a significant reduction in parameters when compared with baseline. Conclusion: Although curcumin has equivalent benefit to chlorhexidine, curcumin being an ayurvedic herb is an excellent alternative to chlorhexidine due to minimal side‑effects.


Assuntos
Adulto , Clorexidina/uso terapêutico , Curcumina/uso terapêutico , Sistemas de Liberação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Periodontais/tratamento farmacológico , Doenças Periodontais/terapia , Adulto Jovem
18.
Egyptian Journal of Histology [The]. 2013; 36 (3): 681-690
em Inglês | IMEMR | ID: emr-187235

RESUMO

Background: Sodium chlorate [NaClO[3]] is found in drinking water, but it has a toxic effect on thyroid. However, curcumin has a thyroid-stimulating effect


Aim of the work: To study the effect of NaClO[3] on the pituitary-thyroid axis of rats and determine the possible protective role of curcumin


Materials and methods: Thirty rats were divided into three groups of 10 rats each. Group I was the control group. In group II, rats received 0.2 g/l of NaClO[3] in drinking water for 3 weeks. In group III, rats received curcumin [100 mg/kg] 1 week before exposure to NaClO[3] and it was continued for 3 weeks. T3, T4, thyroid-stimulating hormone, and superoxide anion were measured. Sections were subjected to H and E, azan stain, caspase-3, and S-100 immunohistochemical stains


Results: In group II, serum T3 and T4 were significantly decreased whereas thyroid-stimulating hormone and superoxide anion were significantly increased compared with the control group. The thyroid gland showed follicular cell hypertrophy, hyperplasia, decreased colloid, and significantly decreased caspase-3 immunoreactivity compared with the control group. The pituitary gland showed significantly increased basophils and significantly decreased S-100-positive folliculostellate cells compared with the control group. In group III, thyroid function tests were significantly improved compared with group II, but did not reach the control level. Thyroid sections appeared apparently normal, with significantly increased caspase-3 immunoreactivity compared with the control group and group II. The pituitary gland showed basophils that were similar to those of the control group. S-100-positive folliculostellate cells were significantly increased compared with group II, but did not reach the control level


Conclusion: Curcumin can protect the thyroid gland from the adverse effects of NaClO[3] and consequently protects the pituitary gland from negative feedback


Assuntos
Animais de Laboratório , Glândula Tireoide/patologia , Hipófise/patologia , Imuno-Histoquímica , Substâncias Protetoras , Curcumina/uso terapêutico , Resultado do Tratamento , Ratos
19.
Perionews ; 7(4): 376-382, 2013. ilus, tab
Artigo em Português | LILACS, BBO | ID: lil-689018

RESUMO

A terapia fotodinâmica (TFD) tem sido utilizada com sucesso em Odontologia e, atualmente, tem sido proposta como alternativa dentro da terapia periodontal. Não existe, porém, um consenso sobre o melhor protocolo clínico de TFD em Periodontia, sendo necessárias pesquisas de novos fotossensibilizadores com finalidade de potencializar o efeito antimicrobiano da TFD sobre o biofilme periodontal e, consequentemente, sobre os parâmetros clínicos periodontais. Dessa forma, sugere-se, nesta revisão da literatura, a curcumina como uma potencial droga fotossensibilizadora para uso em Periodontia. Porém, são necessários estudos que validem um protocolo para seu uso clínico e confirmem sua eficácia no controle das doenças periodontais.


Assuntos
Humanos , Biofilmes , Curcumina/uso terapêutico , Periodontia , Fotoquimioterapia , Periodontite/terapia
20.
Indian J Biochem Biophys ; 2012 Oct; 49(5): 306-315
Artigo em Inglês | IMSEAR | ID: sea-143552

RESUMO

Curcumin is the active component in turmeric — a spice that has been extensively used as a culinary agent and a home remedy to prevent and treat many diseases in India and other countries for hundreds of years. However, systematic studies to understand the molecular basis of disease preventing or therapeutic properties of curcumin began to appear in the scientific literature only during the last 40 years. As a result of these studies, substantial evidence has accumulated to suggest that curcumin can affect signaling pathways linked to cellular growth, proliferation, survival, inflammation and transcription. In addition, curcumin has also been shown to exert anti-atherosclerotic, anti-cancer, anti-diabetic, anti-inflammatory and anti-oxidative properties in animal models of various diseases and in human subjects. In this article, we highlight the cardiovascular protective role of curcumin with an emphasis on the molecular basis of this effect.


Assuntos
Cardiomegalia/dietoterapia , Dieta Aterogênica , Sistema de Sinalização das MAP Quinases , Plantas/uso terapêutico , Curcumina/uso terapêutico , Extratos Vegetais/uso terapêutico , Doença da Artéria Coronariana/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA